Press Releases

Press Releases

July 18, 2018

IRVINE, Calif. , July 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today the pricing of its public offering of 4,000,000 shares of common stock at a public offering price of $20.00 per share, before underwriting discounts and commissions.  The offering consists of

July 16, 2018

IRVINE, Calif. , July 16, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) and commenced a proposed underwritten public offering of 5,000,000 shares of its

June 14, 2018

IRVINE, Calif. , June 14, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company, announced today that members of management will be participating in two upcoming investor conferences in New York, NY .                   Event:   Cantor 2018 Dermatology &

June 4, 2018

IRVINE, Calif. , June 04, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, announced today that Lauren Silvernail , Chief Financial Officer and EVP Corporate

May 16, 2018

IRVINE, Calif. , May 16, 2018 (GLOBE NEWSWIRE) -- Evolus , Inc. (NASDAQ:EOLS) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, announced today that the Company will host a call to discuss regulatory related

May 10, 2018

IRVINE, Calif. , May 10, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today reported financial results for the first quarter ended March 31, 2018 .

Displaying 1 - 10 of 20